YEAR
- 2020.05.05 Development of a Novel Intraocular-Pressure-Lowering Therapy Targeting ATX Nagano N, Honjo M, Kawaguchi M, Nishimasu H, Nureki O, Kano K, Aoki J, Komatsu T, Okabe T, Kojima H, Nagano T, Aihara M.Biol Pharm Bull. 2019;42(11):1926-1935. doi: 10.1248/bpb.b19-00567
- 2020.05.05 Systematic Analysis of Targets of Pumilio-Mediated mRNA Decay Reveals that PUM1 Repression by DNA Damage Activates Translesion Synthesis. Yamada T, Imamachi N, Imamura K, Taniue K, Kawamura T, Suzuki Y, Nagahama M, Akimitsu N.Cell Rep. 2020 May 05;31(5):107542. doi: 10.1016/j.celrep.2020.107542
- 2020.05.05 Systematic Analysis of Targets of Pumilio-Mediated mRNA Decay Reveals that PUM1 Repression by DNA Damage Activates Translesion Synthesis. Yamada T, Imamachi N, Imamura K, Taniue K, Kawamura T, Suzuki Y, Nagahama M, Akimitsu N.Cell Rep. 2020 05 05;31(5):107542. doi: 10.1016/j.celrep.2020.107542
- 2020.05.06 Defined lifestyle and germline factors predispose Asian populations to gastric cancer. Suzuki A, Katoh H, Komura D, Kakiuchi M, Tagashira A, Yamamoto S, Tatsuno K, Ueda H, Nagae G, Fukuda S, Umeda T, Totoki Y, Abe H, Ushiku T, Matsuura T, Sakai E, Ohshima T, Nomura S, Seto Y, Shibata T, Rino Y, Nakajima A, Fukayama M, Ishikawa S, Aburatani H.Sci Adv. 2020 May;6(19):eaav9778. doi: 10.1126/sciadv.aav9778
- 2020.05.07 Comparison of tofogliflozin versus glimepiride as the third oral agent added to metformin plus a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes: A randomized, 24-week, open-label, controlled trial (STOP-OB) Kitazawa T, Seino H, Ohashi H, Inazawa T, Inoue M, Ai M, Fujishiro M, Kuroda H, Yamada M, Anai M, Ishihara H.Diabetes Obes Metab. 2020 09;22(9):1659-1663. doi: 10.1111/dom.14059
- 2020.05.07 Yeast-Based Genetic Interaction Analysis of Human Kinome. Kim JH, Seo Y, Jo M, Jeon H, Lee WH, Yachie N, Zhong Q, Vidal M, Roth FP, Suk K.Cells. 2020 May 07;9(5). doi: 10.3390/cells9051156
- 2020.05.08 Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content. Sasaki Y, Asahiyama M, Tanaka T, Yamamoto S, Murakami K, Kamiya W, Matsumura Y, Osawa T, Anai M, Fruchart JC, Aburatani H, Sakai J, Kodama T.Sci Rep. 2020 May 08;10(1):7818. doi: 10.1038/s41598-020-64902-8
- 2020.05.22 Mesenchymal tumours with RREB1-MRTFB fusion involving the mediastinum: extra-glossal ectomesenchymal chondromyxoid tumours? Makise N, Mori T, Kobayashi H, Nakagawa K, Ryo E, Nakajima J, Kohsaka S, Mano H, Aburatani H, Yoshida A, Ushiku T.Histopathology. 2020 Jun;76(7):1023-1031. doi: 10.1111/his.14080
CLOSE